Drug Type Small molecule drug |
Synonyms |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseIND Approval |
First Approval Date- |
Regulation- |
Molecular FormulaC18H21N3O4 |
InChIKeyGKJKHTUJHRWKJC-CJNGLKHVSA-N |
CAS Registry1353998-41-0 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Primary Parkinson's disease | IND Approval | CN | 09 Jan 2024 |